Skip to main content
. 2023 Nov 13;12(11):15. doi: 10.1167/tvst.12.11.15

Table 2.

Changes in the PEL (mm) and PR (D) at Follow-ups in the Three Groups

Unadjusted Data Adjusted for Sex and Baseline AL
6 Months 12 Months 18 Months 24 Months 6 Months 12 Months 18 Months 24 Months
PEL-T30
 HAL 0.06 ± 0.09 0.13 ± 0.19 0.31 ± 0.37 0.37 ± 0.47 0.06 ± 0.12 0.13 ± 0.16 0.31 ± 0.20 0.37 ± 0.25
 SAL 0.10 ± 0.09 0.22 ± 0.14 0.45 ± 0.19 0.51 ± 0.22 0.09 ± 0.12 0.19 ± 0.17 0.38 ± 0.20 0.48 ± 0.25
 SVL 0.12 ± 0.14 0.16 ± 0.18 0.18 ± 0.22 0.25 ± 0.24 0.10 ± 0.12 0.22 ± 0.16 0.45 ± 0.20 0.51 ± 0.24
PEL-T15
 HAL 0.05 ± 0.11 0.11 ± 0.22 0.24 ± 0.37 0.31 ± 0.48 0.05 ± 0.10 0.11 ± 0.15 0.24 ± 0.21 0.31 ± 0.25
 SAL 0.15 ± 0.11 0.31 ± 0.14 0.53 ± 0.20 0.64 ± 0.23 0.12 ± 0.11 0.23 ± 0.15 0.38 ± 0.21 0.50 ± 0.25
 SVL 0.09 ± 0.11 0.15 ± 0.15 0.19 ± 0.23 0.23 ± 0.27 0.15 ± 0.11 0.31 ± 0.15 0.53 ± 0.21 0.63 ± 0.25
AL
 HAL 0.08 ± 0.13 0.13 ± 0.24 0.25 ± 0.39 0.34 ± 0.51 0.08 ± 0.10 0.13 ± 0.16 0.25 ± 0.21 0.33 ± 0.26
 SAL 0.21 ± 0.11 0.36 ± 0.17 0.57 ± 0.21 0.67 ± 0.25 0.14 ± 0.09 0.24 ± 0.17 0.40 ± 0.22 0.52 ± 0.26
 SVL 0.09 ± 0.08 0.15 ± 0.16 0.20 ± 0.22 0.23 ± 0.28 0.21 ± 0.10 0.36 ± 0.16 0.57 ± 0.22 0.67 ± 0.26
PEL-N15
 HAL 0.10 ± 0.20 0.13 ± 0.25 0.15 ± 0.33 0.39 ± 0.58 0.10 ± 0.26 0.13 ± 0.29 0.15 ± 0.37 0.39 ± 0.36
 SAL 0.19 ± 0.27 0.26 ± 0.28 0.31 ± 0.41 0.57 ± 0.37 0.20 ± 0.26 0.25 ± 0.29 0.33 ± 0.39 0.60 ± 0.36
 SVL 0.21 ± 0.27 0.22 ± 0.33 0.30 ± 0.39 0.28 ± 0.39 0.19 ± 0.26 0.27 ± 0.29 0.31 ± 0.37 0.57 ± 0.36
PEL-N30
 HAL 0.14 ± 0.14 0.20 ± 0.15 0.29 ± 0.29 0.45 ± 0.44 0.13 ± 0.17 0.19 ± 0.18 0.28 ± 0.23 0.44 ± 0.29
 SAL 0.14 ± 0.17 0.17 ± 0.19 0.29 ± 0.24 0.45 ± 0.31 0.14 ± 0.17 0.16 ± 0.19 0.29 ± 0.23 0.45 ± 0.29
 SVL 0.18 ± 0.14 0.17 ± 0.18 0.2 ± 0.23 0.24 ± 0.29 0.14 ± 0.17 0.17 ± 0.18 0.29 ± 0.22 0.45 ± 0.29
PR-T30
 HAL 0.01 ± 0.75 −0.17 ± 0.88 −0.11 ± 0.98 −0.56 ± 0.78 0.01 ± 0.80 −0.17 ± 0.84 0.11 ± 1.03 −0.56 ± 0.84
 SAL −0.27 ± 0.80 −0.46 ± 0.81 −0.13 ± 1.04 −0.70 ± 0.91 −0.29 ± 0.82 −0.46 ± 0.85 −0.14 ± 1.05 −0.67 ± 0.85
 SVL −0.14 ± 0.85 −0.46 ± 0.78 −0.33 ± 1.03 −1.01 ± 0.80 −0.12 ± 0.81 −0.46 ± 0.84 −0.33 ± 1.04 −1.03 ± 0.85
PR-T15
 HAL −0.13 ± 0.47 −0.29 ± 0.62 −0.36 ± 0.57 −0.57 ± 0.65 −0.11 ± 0.40 −0.26 ± 0.52 −0.34 ± 0.56 −0.54 ± 0.60
 SAL −0.13 ± 0.42 −0.48 ± 0.48 −0.50 ± 0.45 −0.88 ± 0.57 −0.14 ± 0.40 −0.48 ± 0.53 −0.51 ± 0.57 −0.89 ± 0.61
 SVL −0.26 ± 0.33 −0.68 ± 0.47 −0.78 ± 0.66 −1.21 ± 0.58 −0.25 ± 0.40 −0.68 ± 0.52 −0.76 ± 0.56 −1.20 ± 0.60
PR-C
 HAL −0.14 ± 0.29 −0.27 ± 0.35 −0.44 ± 0.46 −0.61 ± 0.54 −0.18 ± 0.30 −0.31 ± 0.42 −0.47 ± 0.49 −0.64 ± 0.54
 SAL −0.18 ± 0.28 −0.50 ± 0.37 −0.66 ± 0.42 −0.95 ± 0.50 −0.18 ± 0.31 −0.49 ± 0.43 −0.67 ± 0.50 −0.96 ± 0.55
 SVL −0.32 ± 0.26 −0.77 ± 0.46 −0.98 ± 0.56 −1.34 ± 0.54 −0.32 ± 0.30 −0.77 ± 0.42 −0.98 ± 0.50 −1.33 ± 0.55
PR-N15
 HAL −0.23 ± 0.63 −0.41 ± 0.63 −0.71 ± 0.64 −0.77 ± 0.69 −0.23 ± 0.48 −0.40 ± 0.51 −0.71 ± 0.62 −0.76 ± 0.62
 SAL −0.22 ± 0.37 −0.48 ± 0.37 −0.77 ± 0.51 −0.96 ± 0.53 −0.23 ± 0.49 −0.50 ± 0.52 −0.79 ± 0.64 −0.97 ± 0.63
 SVL −0.27 ± 0.39 −0.67 ± 0.50 −0.88 ± 0.70 −1.13 ± 0.62 −0.27 ± 0.49 −0.66 ± 0.52 −0.86 ± 0.63 −1.12 ± 0.63
PR-N30
 HAL −0.09 ± 0.72 −0.48 ± 0.69 −0.74 ± 0.76 −0.86 ± 0.82 −0.09 ± 0.63 −0.49 ± 0.69 −0.75 ± 0.71 −0.86 ± 0.76
 SAL −0.10 ± 0.53 −0.41 ± 0.66 −0.60 ± 0.58 −0.85 ± 0.71 −0.11 ± 0.64 −0.40 ± 0.70 −0.59 ± 0.72 −0.85 ± 0.77
 SVL −0.07 ± 0.61 −0.51 ± 0.71 −0.60 ± 0.78 −0.82 ± 0.70 −0.06 ± 0.64 −0.51 ± 0.70 −0.62 ± 0.72 −0.82 ± 0.76

Data are presented as the mean ± SD.

T, temporal; N, nasal; C, central; AL, axial length; M, male; SE, spherical equivalent.